Pyxis Oncology Inc

PYXSNASDAQ · USD
2.90USD0.00 (+1.40%)
1210

Pyxis Oncology Inc (PYXS) Unusual Options Activity Today

PYXS options volume power reached 0.36x on the previous trading day. The highest reading was on the $5 CALL expiring 2027-04-16.

Read more

Checking PYXS unusual options activity helps you spot when traders are making outsized bets on Pyxis Oncology Inc before the broader market catches on. Pyxis Oncology Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor PYXS unusual options activity today and surface the prints that deserve a second look.

Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching PYXS unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking PYXS unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and PYXS unusual options flow data becomes especially valuable around earnings, product launches, and macro events.

Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, non-small cell lung cancer (NSCLC), and other solid tumors; and PYX-102, an investigational immune-therapeutic for treatment of solid tumors. The company's antibody drug conjugate (ADC) product candidates comprise of PYX-201, an investigational novel ADC to treat NSCLC, breast cancer, and other solid tumors; PYX-202, an investigational novel ADC for treatment of SCLC, soft tissue sarcoma, and other solid tumors; and PYX-203, an investigational ADC for the treatment of acute myeloid leukemia and myeloid dysplastic syndrome.

The company was incorporated in 2018 and is headquartered in Cambridge, Massachusetts.

Catalysts rarely arrive without a footprint, and PYXS unusual options activity is often where that footprint shows up first. Our scanner tracks Pyxis Oncology Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at PYXS unusual options volume on the call side or chasing put sweeps, Pyxis Oncology Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.

2026-10-16
Calls
2.500.300.600.4587%203655.48%
1.500.901.651.2828%11350.74%
5.00—0.100.10197%203,5530.56%
0.502.052.752.40498%010.00%
1.001.552.301.93346%0250.00%
Puts
5.002.002.652.33246%21271.57%
2.500.150.250.20140%22090.96%
0.50—0.050.05530%0150.00%
1.00—0.050.05326%020.00%
1.50—0.750.75749%00—

As of September 25, 2026

Spot unusual options activity before it moves

Track PYXS options flow across every expiration, filter by volume power, and find the setups with abnormal activity before the trade is gone.

Start your 14-day free trial